Schedule 13G ownership disclosure
Rhythm Pharmaceuticals Inc
COM · CUSIP: 76243J105
Event date: 2025-03-31
- Filing-level shares
- 5,787,322
- Percent of class
- 9.15%
- PRIMECAP MANAGEMENT CO/CA/
Shares: 5,787,322 · Class: 9.15%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-003064
- Form type
- SCHEDULE 13G/A
- Filer
- PRIMECAP MANAGEMENT CO/CA/
- CIK
- CIK 763212
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership